Directive 2003/63/EC
E1533648
UNEXPLORED
Directive 2003/63/EC is a European Union legislative act that updates and refines the rules on the authorisation, supervision, and information requirements for medicinal products for human use established under Directive 2001/83/EC.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Directive 2003/63/EC canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T22404540 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Directive 2003/63/EC Context triple: [Directive 2001/83/EC, amendedBy, Directive 2003/63/EC]
-
A.
Directive 2001/83/EC
Directive 2001/83/EC is a key European Union law that sets the framework for the authorization, manufacture, distribution, and pharmacovigilance of medicinal products for human use across EU member states.
-
B.
Directive 2006/86/EC
Directive 2006/86/EC is a European Union legal act that sets detailed technical requirements for the traceability, notification of serious adverse reactions and events, and quality and safety standards for human tissues and cells used in medical treatments.
-
C.
Directive 2002/58/EC
Directive 2002/58/EC is a European Union directive that sets out rules on privacy and data protection in the electronic communications sector, complementing the broader EU data protection framework.
-
D.
Directive 2007/64/EC
Directive 2007/64/EC is a European Union directive that established a harmonized legal framework for payment services within the EU, promoting competition, transparency, and consumer protection in the payments market.
-
E.
Directive 2003/41/EC
Directive 2003/41/EC was the original EU framework setting prudential and supervision rules for institutions for occupational retirement provision (IORPs) before being updated and replaced by the IORP II Directive.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Directive 2003/63/EC Target entity description: Directive 2003/63/EC is a European Union legislative act that updates and refines the rules on the authorisation, supervision, and information requirements for medicinal products for human use established under Directive 2001/83/EC.
-
A.
Directive 2001/83/EC
Directive 2001/83/EC is a key European Union law that sets the framework for the authorization, manufacture, distribution, and pharmacovigilance of medicinal products for human use across EU member states.
-
B.
Directive 2006/86/EC
Directive 2006/86/EC is a European Union legal act that sets detailed technical requirements for the traceability, notification of serious adverse reactions and events, and quality and safety standards for human tissues and cells used in medical treatments.
-
C.
Directive 2002/58/EC
Directive 2002/58/EC is a European Union directive that sets out rules on privacy and data protection in the electronic communications sector, complementing the broader EU data protection framework.
-
D.
Directive 2007/64/EC
Directive 2007/64/EC is a European Union directive that established a harmonized legal framework for payment services within the EU, promoting competition, transparency, and consumer protection in the payments market.
-
E.
Directive 2003/41/EC
Directive 2003/41/EC was the original EU framework setting prudential and supervision rules for institutions for occupational retirement provision (IORPs) before being updated and replaced by the IORP II Directive.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.